Literature DB >> 22814958

Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita.

Deniz Aslan1, Rustu F Akata, Harriet Holme, Tom Vulliamy, Inderjeet Dokal.   

Abstract

The aim of this study is to present the limbal stem cell deficiency (LSCD) cases with features resembling dyskeratosis congenita (DC), a heritable disease of stem cells principally caused by telomerase deficiency. The clinical, laboratory and molecular findings of four cases are presented. A complete systemic examination was performed in a standardized manner for each patient. Laboratory measurements included investigations of the tests used for screening DC. All eight known disease-causing genes in DC (DKC1, TERC, TERT, NOP10, NHP2, TINF2, C16orf57, and TCAB1) were screened for mutations. The family members of the cases were also assessed, when possible. In all four patients, multisystem involvement was present, along with the disorder affecting corneal LSCs. The affected tissues were mainly the skin and its adnexa, the oral cavity and the hematopoietic system, which are rapidly renewing tissues, consistent with the presence of a stem cell disorder. Similarly affected cases were seen in different generations in families, suggesting an underlying inherited disorder. No mutation was detected in any of the known disease-causing genes in these patients. Based on the presented cases and with the contribution of the review of previously reported DC cases available, we suggest that DC is one of the inherited causes of LSCD and that those cases presenting with LSCD might represent a subgroup of DC caused by mutations in an as yet undefined gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814958     DOI: 10.1007/s10792-012-9611-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  19 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

3.  [Experimental research of the expression of telomerase in corneal limbal epithelial cells].

Authors:  Hong Chen; Ming-chang Zhang; Yan-hua Hu
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2005-05

Review 4.  Corneal epithelial stem cells in health and disease.

Authors:  Julie T Daniels; Anna R Harris; Chris Mason
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

5.  Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.

Authors:  Franklin Zhong; Sharon A Savage; Marina Shkreli; Neelam Giri; Lea Jessop; Timothy Myers; Renee Chen; Blanche P Alter; Steven E Artandi
Journal:  Genes Dev       Date:  2011-01-01       Impact factor: 11.361

6.  Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.

Authors:  Ekaterini T Tsilou; Neelam Giri; Sarah Weinstein; Christine Mueller; Sharon A Savage; Blanche P Alter
Journal:  Ophthalmology       Date:  2009-12-22       Impact factor: 12.079

Review 7.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07

8.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

9.  TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.

Authors:  Sharon A Savage; Neelam Giri; Gabriela M Baerlocher; Nick Orr; Peter M Lansdorp; Blanche P Alter
Journal:  Am J Hum Genet       Date:  2008-01-31       Impact factor: 11.025

10.  Dyskeratosis congenita and limbal stem cell deficiency.

Authors:  Deniz Aslan; Rustu Fikret Akata
Journal:  Exp Eye Res       Date:  2009-12-27       Impact factor: 3.467

View more
  6 in total

Review 1.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

2.  Homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes.

Authors:  Hemanth Tummala; Laura C Collopy; Amanda J Walne; Alicia Ellison; Shirleny Cardoso; Tekin Aksu; Nese Yarali; Deniz Aslan; Rüştü Fikret Akata; Juliana Teo; Zhou Songyang; Nikolas Pontikos; Jude Fitzgibbon; Kazunori Tomita; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2018-07-31       Impact factor: 25.476

Review 3.  Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies.

Authors:  Michel Haagdorens; Sara Ilse Van Acker; Veerle Van Gerwen; Sorcha Ní Dhubhghaill; Carina Koppen; Marie-José Tassignon; Nadia Zakaria
Journal:  Stem Cells Int       Date:  2015-12-14       Impact factor: 5.443

4.  Dyskeratosis Congenita and Corneal Refractive Surgery.

Authors:  Madeline B Heiland; Majid Moshirfar; David B Rosen; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Ophthalmol Ther       Date:  2019-07-16

Review 5.  Presentation, diagnosis and management of limbal stem cell deficiency.

Authors:  Kunjal Sejpal; Pejman Bakhtiari; Sophie X Deng
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

6.  Zinsser-Engman-Cole Syndrome Presenting as Partial Limbal Stem Cell Deficiency.

Authors:  Arjun Srirampur; Tarannum Mansoori; Pravalika Rebbala
Journal:  Cureus       Date:  2020-10-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.